Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microdermis was a life sciences company based in Princeton, New Jersey, that specialized in advanced dermatological products using its proprietary Amidermal technology. The company's flagship product, Provodine, is a long-acting, alcohol-free antiseptic cream that creates a molecular barrier on the skin to provide persistent protection against a broad spectrum of pathogens, including the Ebola virus and MRSA. Microdermis collaborated with the US Army (USAMRIID) to deploy Provodine during infectious disease outbreaks and conducted clinical trials for indications such as Hidradenitis Suppurativa. Despite its innovative approach to skin protection and infection control, the company is currently reported as out of business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microdermis.